The patient was an 84-year-old 
Introduction

It is well known that malignant pleurisy is complicated with various malignant diseases. Massive pleural effusion aggravates the patient's cough and dyspnea, resulting in impairment of their quality of life (QOL). Lung cancer is the leading cause of malignant pleurisy, and 15% of lung cancer cases are complicated with concomitant pleural effusion at the time of diagnosis (1). Pleurodesis with chemical agents is often performed in patients with malignant pleurisy associated with lung cancer, especially for non-small cell lung cancer (NSCLC) due to the difficulty in management of
F i g u r e 1 . Ch e s t r a d i o g r a p h r e v e a l e d a ma s s l e s i o n i n t h e r i g h t h i l u m o f l u n g a n d r i g h t p l e u r a l e f f u s i o n ( 1 A) . T h o r a c i c c o mp u t e d t o mo g r a p h y ( CT ) r e v e a l e d a ma s s l e s i o n l o c a t e d a t S 6
o f t h e r i g h t l u n g a n d r i g h t p l e u r a l e f f u s i o n ( 1 B ) .
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F i g u r e 2 . Ch e s t r a d i o g r a p h o n r e -a d mi s s i o n s h o we d a ma r k e d i n c r e a s e i n t h e r i g h t p l e u r a l e f f u s i o n .
lung and the diagnosis for pulmonary adenocarcinoma was established. Moreover, we also detected a small amount of right pleural effusion (Fig. 1A) T a b l e 1 . L a b o r a t o r y Da t a b e f o r e a n d a f t e r P l e u r o d e s i s wi t (5, 6, 8) , talc (7, 8) , and so on. Although the success rates of pleurodesis using OK-432 and talc are 88% (5) and over 90% (8) 
Discussion
Pleural effusion is known to be produced from the parietal pleura and absorbed into the visceral pleura. In general, the balance between production and absorption of fluid is spontaneously achieved, thus, pleural effusion is maintained at the level of 5-20 mL in normal subjects (4). In patients with malignant pleurisy, both increased production of fluid in the pleural space and decreased absorption of fluid into the visceral pleura are postulated to be the main mechanisms involved. The conventional chemical pleurodesis is the treatment that leads to the decrease of the pleural space by adhesion between the visceral and parietal pleura using chemical agents, such as OK-432
F i g u r e 3 . Af t e r o n e y e a r o f p l e u r o d e s i s , b o t h c h e s t r a d i o g r a p h ( 3 A) a n d CT ( 3 B ) r e v e a l e d a ma r k e d i n c r e a s e i n t h e s i z e o f t h e p u l mo n a r y t u mo r . Ho we v e r , n o i n c r e a s e i n p l e u r a l e f f u s i o n wa s o b s e r v e d .
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reported that pleurodesis using DW was effective in two patients with malignant effusion complicated with breast cancer (10) . Although they were followed up for only 30 days after pleurodesis, this period is sufficient to reveal the cytotoxicity and the inhibitory effect of DW on the cell growth of cancer cells (3) 
